McDermott Will & Emery represented Inhibikase Therapeutics in the transaction. Inhibikase Therapeutics, Inc. (Inhibikase), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the...
Inhibikase Therapeutics’ $4 Million Common Stock Offering
Zura Bio’s Business Combination with JATT Acquisition Corp.
McDermott Will & Emery and Ogier represented Zura Bio. Loeb & Loeb and Simmons & Simmons represented JATT and Maples and Calder (Cayman) acted as Cayman...
CHW Acquisition Corporation’s $350 Million De-SPAC With Wag Labs
McDermott Will & Emery represented CHW Acquisition Corporation, while Cleary Gottlieb Steen & Hamilton represented Wag! in the transaction. CHW Acquisition Corporation (CHW), a publicly traded...
Papaya Growth Opportunity Corp. I’s $250 Million Initial Public Offering
McDermott Will & Emery represented Papaya Growth Opportunity Corp. I in the transaction. Papaya Growth Opportunity Corp. I (NASDAQ: PPYAU), a newly incorporated blank check company,...
TeleSign’s Business Combination With North Atlantic Acquisition Corporation
Reed Smith and McDermott Will & Emery LLP acted as legal counsel to NAAC. Sidley Austin acted as legal counsel to Morgan Stanley and J.P. Morgan...
Shield AI’s Acquisition of Heron Systems
Reed Smith has advised Shield AI on its acquisition of Heron Systems, Inc. Together, Shield AI and Heron will accelerate the deployment of advanced AI-pilots to...
BuzzFeed’s $300 Million Acquisition of Complex Networks
Fenwick & West LLP represented BuzzFeed, while Reed Smith LLP represented Complex Networks in the transaction. Reed Smith also represented Verizon and Hearst in their capacity...
Tech Mahindra’s $120 Million Acquisition of DigitalOnUs
Reed Smith advised Tech Mahindra on the deal. Tech Mahindra (NSE: TECHM), a leading provider of digital transformation, consulting, and business re-engineering services and solutions, executed its...